P709-0885 Screening compound: 1-[5-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-5-methyl-N-[(thiophen-2-yl)methyl]-1H-pyrazole-4-carboxamide

P709-0885 Screening compound: 1-[5-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-5-methyl-N-[(thiophen-2-yl)methyl]-1H-pyrazole-4-carboxamide
P709-0885 Screening compound: 1-[5-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-5-methyl-N-[(thiophen-2-yl)methyl]-1H-pyrazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P709-0885
1-[5-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-5-methyl-N-[(thiophen-2-yl)methyl]-1H-pyrazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P709-0885

Molecular Formula

C20H18N6O2S (C20 H18 N6 O2 S)

Compound Name

1-[5-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-5-methyl-N-[(thiophen-2-yl)methyl]-1H-pyrazole-4-carboxamide

IUPAC name

1-[5-(3-cyclopropyl-124-oxadiazol-5-yl)pyridin-2-yl]-5-methyl-N-[(thiophen-2-yl)methyl]-1H-pyrazole-4-carboxamide

SMILES

Cc(n(-c(cc1)ncc1-c1nc(C2CC2)no1)nc1)c1C(NCc1cccs1)=O

InChI

InChI=1S/C20H18N6O2S/c1-12-16(19(27)22-10-15-3-2-8-29-15)11-23-26(12)17-7-6-14(9-21-17)20-24-18(25-28-20)13-4-5-13/h2-3,6-9,11,13H,4-5,10H2,1H3,(H,22,27)

InChI Key

NRSGHHYYHKDZMF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27613462

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

406.47

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.008

Distribution Coefficient, logD

4.006

Water Solubility, LogSw

-4.12

Polar Surface Area

80.265

Acid Dissociation Constant (pKa)

12.63

Base Dissociation Constant (pKb)

5.08

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

P709-0885 in Drug Discovery

Included in Screening Libraries

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P709-0885 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P709-0885?
Check Price and Availability of P709-0885, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P709-0885 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P709-0885
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P709-0885
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P709-0885 available by request